FOSTER CITY, Calif.--(BUSINESS WIRE)--May 2, 2017--
Gilead Sciences, Inc. (Nasdaq:GILD) today announced that the company’s
Board of Directors has declared a cash dividend of $0.52 per share of
common stock for the second quarter of 2017. The dividend is payable on
June 29, 2017, to stockholders of record at the close of business on
June 16, 2017. Future dividends will be subject to Board approval.
Gilead Sciences is a biopharmaceutical company that discovers, develops
and commercializes innovative therapeutics in areas of unmet medical
need. The company’s mission is to advance the care of patients suffering
from life-threatening diseases. Gilead has operations in more than 30
countries worldwide, with headquarters in Foster City, California.
For more information on Gilead Sciences, please visit the company’s
website at www.gilead.com,
follow Gilead on Twitter (@GileadSciences) or call Gilead Public Affairs
at 1-800-GILEAD-5 or 1-650-574-3000.